Delivery Order SPE2DB20D3101-SPE2DB25FRQS5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.90 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its ongoing federal medical procurement activities...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $149,035.14 for TWINRIX vaccine in syringe format on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical medical supply needs through the federal procurement process. The contract is performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $12,089.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Twinrix vaccine syringes. The delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide the specified vaccines to the DLA by August 7, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a leading distributor of pharmaceuticals and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the TWINRIX vaccine. The $7,668.94 firm-fixed-price contract has an ultimate completion date of August 20, 2024. AmerisourceBergen, through its Corporate Office division, will provide the TWINRIX vaccine syringes to support the DLA's medical supply requirements. This order is placed under an Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of TWINRIX VACCINE SYRINGEML. The award has a ceiling value of $14,927.78 and an ultimate completion date of August 20, 2024. The contract is a Firm Fixed Price type. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- The U.S. Defense Logistics Agency (DLA) awarded a $50,490.88 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the federal government. This order is for Twinrix vaccine syringes and has a completion date of May 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a subsidiary of the Cencora, Inc. parent company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred two thousand one hundred fifty dollars and fifty-five cents ($102,150.55) to Amerisourcebergen Drug Corporation for the delivery of Twinrix vaccine syringes. The delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle and calls for the shipment of vaccines to a facility located in Conshohocken, Pennsylvania by July 31, 2023. As a leading provider of medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Twinrix vaccine syringes. The $3,140.88 firm fixed-price contract has a performance period through May 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which acts as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQS5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $47,667.15 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical federal medical supply vendor, regularly fulfilling Defense Logistics Agency procurement requirements for pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to deliver diverse therapeutic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This Twinrix vaccine delivery order exemplifies the company's role as a reliable supplier of immunization products to federal healthcare programs, leveraging its comprehensive pharmaceutical prime vendor contract with DLA to support military medical readiness requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.7k | 7/21/25 |